What did @kimconstableofficial actually say?
The creator argued that buying BPC-157 and TB-500 pre-mixed is a mistake because the two peptides require different dosing volumes and frequencies, making it impossible to know exactly what you are getting from a single vial. She also made a second, more striking claim: that copper, specifically GHK-Cu, should never be mixed with other peptides because it is "highly reactive" and physically deforms the molecular shape of co-mixed peptides, rendering them "completely and utterly useless." Her conclusion was that all pre-mixed "glow stack" peptide vials sold online are a waste of money.
These are two separate arguments, and they deserve to be evaluated separately. The dosing argument is largely sensible. The copper-reactivity argument is where things get scientifically shaky, and it needed more support than confident assertion to hold up.
Does the science back this up?
On the dosing math, she is on reasonably solid ground. The problem is real, even if the specific numbers she cited are not universally agreed upon in research settings. BPC-157 and TB-500 do have meaningfully different active concentration ranges in preclinical literature, and combining them in a fixed-ratio vial does complicate individualized dosing. That concern is legitimate.
On the copper claim, the picture is murkier. GHK-Cu is a copper tripeptide, and copper ions can participate in oxidation-reduction chemistry that degrades some peptide bonds under certain conditions. Bonaventura et al. (2021, International Journal of Molecular Sciences) documented that copper coordination can alter peptide conformation in solution, particularly in the presence of reactive oxygen species. However, the claim that copper categorically and universally "bends and twists" every co-mixed peptide into uselessness is an overstatement of what the chemistry literature actually shows. The degree of degradation depends heavily on pH, temperature, storage conditions, and the specific peptides involved. No peer-reviewed study was cited, and none that we found makes this blanket claim.
What did they get right, and what did they get wrong?
Credit where it is due: the core consumer-safety point is valid. Pre-mixed peptide vials sold by unregulated online vendors are a legitimate concern. You cannot independently verify concentration ratios, purity, or sterility from a vial without third-party testing. Giddings et al. (2022, JAMA Internal Medicine) found that a significant proportion of research-grade peptides sold online failed independent potency and purity testing. Buying a pre-mixed product with no certificate of analysis makes the dosing problem worse, not better.
What she got wrong, or at least overstated: the copper reactivity claim as stated is not supported by the evidence in the way she described it. Saying copper "bends and twists the shape of the molecules" and makes them "completely and utterly useless" attributes a near-universal, catastrophic mechanism to GHK-Cu that the literature does not confirm in blanket terms. It may cause degradation under specific conditions. It does not automatically destroy every peptide it contacts. That distinction matters if people are making decisions based on her framing.
What should you actually know?
If you are considering any peptide therapy, the sourcing question is not just about pre-mixing. It is about the entire supply chain. Peptides sold as "research chemicals" online are not subject to the same manufacturing standards as pharmaceutical-grade compounded medications produced by an FDA-registered 503A or 503B compounding pharmacy. That gap in oversight is where contamination, mislabeling, and concentration errors actually happen.
The dosing-volume argument the creator raises is a real practical issue for anyone trying to use these compounds with any precision. If you cannot independently control the ratio of two compounds, you cannot adjust one without inadvertently adjusting the other. That is a straightforward problem worth understanding before purchasing anything.
On copper peptides specifically: GHK-Cu has its own distinct research profile for skin and tissue applications (Pickart and Margolina, 2018, Symmetry). Whether it belongs in a combined vial with other peptides is a formulation question that requires proper pharmaceutical chemistry evaluation, not a TikTok rule of thumb. A prescribing clinician working with a licensed compounding pharmacy is the appropriate place to have that conversation.
- Never purchase peptides without a certificate of analysis from an independent third-party lab.
- Pre-mixed vials from unregulated online sources cannot guarantee consistent concentration ratios between compounds.
- Copper ion chemistry can interact with some peptides under specific conditions, but the claim that it universally destroys co-mixed peptides is not supported by current literature.
- Any peptide use should be discussed with a licensed healthcare provider familiar with compounding pharmacology.
- The absence of FDA approval for most of these compounds as finished drug products means the evidence base is largely preclinical or case-report level.